Company Filing History:
Years Active: 2020
Title: Hyeon-Seok Eom: Innovator in Cancer Treatment
Introduction
Hyeon-Seok Eom is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative methods for isolating and proliferating autologous cancer antigen-specific CD8T cells. With a total of 2 patents, his work focuses on harnessing the body's own immune response to combat cancer effectively.
Latest Patents
Hyeon-Seok Eom's latest patents include methods for isolating and proliferating autologous cancer antigen-specific CD8T cells. These methods involve selecting an epitope recognized by CD8T cells from autologous cancer antigens present in the blood of individual cancer patients. By using a peptide of the selected epitope, Eom's methods allow for the isolation of these specific T cells. This innovative approach enables the effective selection and elimination of cancer cells derived from the patient's own cells, thus minimizing side effects associated with traditional treatments.
Career Highlights
Throughout his career, Hyeon-Seok Eom has worked with esteemed organizations such as the National Cancer Center and Eutilex Co., Ltd. His experience in these institutions has allowed him to develop groundbreaking techniques that advance cancer treatment.
Collaborations
Hyeon-Seok Eom has collaborated with notable colleagues, including Byoung S Kwon and Hyun-Guy Kang. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
Hyeon-Seok Eom is a key figure in the field of cancer treatment, with his innovative patents paving the way for more effective and less invasive therapies. His work exemplifies the potential of utilizing the body's immune system to fight cancer, offering hope for patients worldwide.